,

Wegovy

Price range: £125.00 through £254.00

Consultation for Weight loss

Costs incl. consult & service fee.

  • Fast home delivery
  • Discreet
  • Professional and knowledgeable

PRODUCT DETAILS

Wegovy (Retatrutide) is a developing triple hormone receptor agonist (GIP, GLP-1, and glucagon receptors) that is now being tested in clinical studies to treat obesity, type 2 diabetes, and metabolic disorders.

It is regarded as a next-generation weight loss medicine, perhaps more successful than both semaglutide and tirzepatide.

• Works by activating three metabolic hormone receptors:

◦ GLP-1: improves insulin release, reduces appetite.

◦ GIP: enhances insulin sensitivity, supports energy balance.

◦ Glucagon: increases energy expenditure and promotes fat burning.

This threefold action gives Retatrutide a potent metabolic effect on weight loss, blood sugar levels, and overall energy balance.

BENEFITS OF Wegovy:

Extreme Weight Loss

• Up to 24% body weight reduction in trials (even higher than tirzepatide).

• Some participants lost 60+ pounds over 48–72 weeks.

• Among the most effective weight loss drugs ever tested.

Improves Blood Sugar in Type 2 Diabetes

• Strong HbA1c reductions (1.8–2.2% or more).

• Supports glucose control across fasting and post-meal periods.

 

Increases Energy Expenditure

• Unlike semaglutide or tirzepatide, Retatrutide’s glucagon activation helps burn more calories.

• Enhances fat oxidation and reduces fat storage.

 

Improves Liver Health

• Shown to reduce liver fat in patients with NAFLD/NASH.

• May slow or reverse early liver damage (inflammation/fibrosis).

 

Enhances Cardiometabolic Markers

Reduces:

◦ Triglycerides

◦ LDL cholesterol

◦ Blood pressure

◦ Inflammatory markers

• Improves insulin sensitivity.

 

Preserves Muscle Mass

• Similar to tirzepatide, early trials suggest lean mass retention during weight loss.

• Supports healthier body composition (fat loss > muscle loss).

 

Suppresses Appetite

• Stronger appetite suppression than GLP-1 or GLP-1/GIP drugs alone.

• Enhances satiety, reduces cravings and emotional eating.

 

Improves Quality of Life

• Participants reported:

◦ Better energy

◦ Greater mobility

◦ Fewer obesity-related symptoms

◦ Better mental and emotional health

 

Dosage

0.25mg, 0.5mg, 1.0mg, 1.7mg, 2.4mg

Reviews

There are no reviews yet.

Be the first to review “Wegovy”

Your email address will not be published. Required fields are marked *

Scroll to Top